104 related articles for article (PubMed ID: 12196072)
1. Enoxaparin safety in patients with severe thrombocytopenia.
Ibrahim RB; Stroempl LE; Abella EM; Racine E
Ann Pharmacother; 2002 Sep; 36(9):1478-9. PubMed ID: 12196072
[No Abstract] [Full Text] [Related]
2. Enoxaparin can be used safely in patients with severe thrombocytopenia due to intensive chemotherapy regimens.
Herishanu Y; Misgav M; Kirgner I; Ben-Tal O; Eldor A; Naparstek E
Leuk Lymphoma; 2004 Jul; 45(7):1407-11. PubMed ID: 15359641
[TBL] [Abstract][Full Text] [Related]
3. Enoxaparin (Clexane) HITS.
Watters M
Anaesth Intensive Care; 1996 Oct; 24(5):616-7. PubMed ID: 9027216
[No Abstract] [Full Text] [Related]
4. Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients: a case series and review of the literature.
Ibrahim RB; Peres E; Dansey R; Abidi MH; Abella EM; Gumma MM; Milan N; Smith DW; Heilbrun LK; Klein J
Bone Marrow Transplant; 2005 Jun; 35(11):1071-7. PubMed ID: 15821771
[TBL] [Abstract][Full Text] [Related]
5. A Rare Case of Enoxaparin-Induced Skin Necrosis Without Thrombocytopenia.
Li J; Inwald G; Thomas M
Am J Phys Med Rehabil; 2019 May; 98(5):e51. PubMed ID: 30252691
[No Abstract] [Full Text] [Related]
6. Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients.
Or R; Elad S; Shpilberg O; Eldor A
Am J Hematol; 1996 Sep; 53(1):46-8. PubMed ID: 8813098
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytosis after prophylactic administration of enoxaparin: unexpected findings in a Polish prospective multicenter trial on the efficacy and safety of enoxaparin in the prevention of postoperative thromboembolism.
Ziaja K; Simka M; Krupowies A; Dugaj M; Ludyga T
Int Angiol; 1999 Mar; 18(1):65-9. PubMed ID: 10392483
[TBL] [Abstract][Full Text] [Related]
8. Sonographic diagnosis of venocclusive disease of the liver and danazol therapy for autoimmune thrombocytopenia in an autologous marrow transplant patient.
Matsuishi E; Anzai K; Dohmen K; Taniguchi S; Gondo H; Kudo J; Shibuya T; Ishibashi H; Harada M; Niho Y
Jpn J Clin Oncol; 1990 Jun; 20(2):188-92. PubMed ID: 2196389
[TBL] [Abstract][Full Text] [Related]
9. [Enoxaparin-induced hepatotoxicity].
Zaera De La Fuente C; Arribas Anta J; López-San Román A; Cañete Ruiz Á; López Durán S
Gastroenterol Hepatol; 2015; 38(7):438-9. PubMed ID: 25155866
[No Abstract] [Full Text] [Related]
10. Coagulation: cascade!
Olah Z; Bereczky Z; Szarvas M; Boda Z
Lancet; 2011 Aug; 378(9792):740. PubMed ID: 21856488
[No Abstract] [Full Text] [Related]
11. Cardiopulmonary bypass for heparin-induced thrombocytopenia: management with a heparin-bonded circuit and enoxaparin.
Ganjoo AK; Harloff MG; Johnson WD
J Thorac Cardiovasc Surg; 1996 Nov; 112(5):1390-2. PubMed ID: 8911341
[No Abstract] [Full Text] [Related]
12. Heparin Skin Necrosis in Heparin-Induced Thrombocytopenia.
Pasha AK; McBane Ii RD
Mayo Clin Proc; 2021 Sep; 96(9):2492. PubMed ID: 34481603
[No Abstract] [Full Text] [Related]
13. Use of enoxaparin in patients with chronic kidney disease: safety considerations.
Brophy DF; Sica DA
Drug Saf; 2007; 30(11):991-4. PubMed ID: 17973538
[No Abstract] [Full Text] [Related]
14. Hemorrhagic transformation of ischemic stroke associated with enoxaparin and aspirin concomitant therapy.
Calvo-Romero JM
Cardiovasc Drugs Ther; 2004 Jan; 18(1):77-8. PubMed ID: 15115906
[No Abstract] [Full Text] [Related]
15. Fatal retroperitoneal haemorrhage associated with enoxaparin and impaired renal function.
Quiles J; Avanzas P; Bueno H
Int J Cardiol; 2005 Feb; 98(3):523-4. PubMed ID: 15708194
[No Abstract] [Full Text] [Related]
16. [Enoxaparin-induced thrombocytopenia with associated arterial and venous thrombosis].
Iturbe T; Español I; Sánchez A; Rivera J
Med Clin (Barc); 2011 Jan; 136(1):38-9. PubMed ID: 19822333
[No Abstract] [Full Text] [Related]
17. [Enoxaparin dosage in extreme obesity by monitoring anti-Xa factor].
Andújar Mateos A; Matoses Chirivella C; Rodríguez Lucena FJ; Navarro Ruiz A
Farm Hosp; 2016 Jan; 40(1):58-9. PubMed ID: 26882836
[No Abstract] [Full Text] [Related]
18. Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with acute coronary syndromes.
Yeh RW; Wiviott SD; Giugliano RP; Morrow DA; Shui A; Qin J; Scirica B; Bradner JE; Jang IK; Gibson CM; Antman EM
Am J Cardiol; 2007 Dec; 100(12):1734-8. PubMed ID: 18082517
[TBL] [Abstract][Full Text] [Related]
19. Systemic bleeding in a patient with enoxaparin-induced thrombocytopenia.
Famularo G; Gasbarrone L; Minisola G; De Simone C
Am J Emerg Med; 2009 Jul; 27(6):756.e1-2. PubMed ID: 19751647
[No Abstract] [Full Text] [Related]
20. Fatal haemorrhage associated with enoxaparin.
Crooke B; Callaway LK
Intern Med J; 2007 Mar; 37(3):207-8. PubMed ID: 17316348
[No Abstract] [Full Text] [Related]
[Next] [New Search]
